全球狂犬病诊断市场规模（依诊断方法、技术、地区和预测）

狂犬病诊断药物市场规模及预测

预计狂犬病诊断市场在 2024 年的价值将达到 19 亿美元，到 2031 年将达到 38 亿美元，2024 年至 2031 年的复合年增长率为 4.9%。

推动全球狂犬病诊断市场的因素

狂犬病诊断市场的驱动因素可能受到多种因素的影响。这些因素包括：

狂犬病发病率上升：越来越需要狂犬病诊断来识别患有狂犬病的动物并防止其传播给人类，特别是在疫苗接种计划不普遍的地区。

政府法规和措施：野生动物和宠物强制狂犬病疫苗接种计画是政府主导的狂犬病控制措施的例子，这些措施可能会增加对狂犬病诊断产品的需求。动物进出口监管法律也可能影响市场环境。

技术进步：分子诊断（PCR）、次世代定序和快速免疫诊断测试等诊断技术的进步使得狂犬病诊断更加准确、快速和方便，从而扩大了市场。

宠物数量的增加：随着全球宠物拥有量的增加，对狗、猫和其他家养动物进行狂犬病检测的需求也随之增加。

有关狂犬病感染风险和早期诊断价值的公众意识提升宣传活动和教育措施可以成为狂犬病诊断需求的主要驱动力。

全球旅行与旅游：由于狂犬病跨境传播的风险增加，游客涌入较多的地区需要强大的诊断基础设施。

动物福利问题：人们对动物福利和对待动物的道德意识的提高增加了对准确和富有同情心的狂犬病检测技术的需求，并鼓励使用尖端诊断技术。

疫情防治：为了快速发现和控制狂犬病疫情，特别是在疫情易发地区，政府和医疗机构将投资狂犬病诊断作为其防治计画的一部分。

研究与发展：旨在提供狂犬病创新诊断、疫苗接种和治疗方法的持续研究与开发创造了新的机会并刺激了创新，为诊断行业的扩张做出了贡献。

伙伴关係与协作：政府机构、研究中心和诊断公司之间的联盟和协作汇集资源和专业知识，以加速新诊断设备的开发和商业化，有助于扩大市场。

限制全球狂犬病诊断市场的因素

狂犬病诊断市场可能面临多种限制和挑战，包括：

监管障碍：诊断检测的严格监管和冗长的核准程序可能会阻碍市场扩张。对于推出新诊断产品的公司来说，合规性可能是一个重大障碍。

基础设施和意识有限：狂犬病流行的地区可能缺乏医疗保健基础设施来提供广泛的检测或了解诊断的重要性。

成本高：诊断测试可能很昂贵，特别是在资源有限的环境中，这可能使诊断难以获得，特别是在患病率高的地区。

技术限制：目前的诊断技术在灵敏度、特异性和检测速度方面有其限制。为了克服这些局限性，需要创新诊断方法。

狂犬病的地理分布：由于狂犬病在世界某些地区发病率较高，因此在发病率较低的地区，诊断产品的市场机会可能较少。

与替代方法的竞争：在资源匮乏且更倾向于经济解决方案的环境中，狂犬病诊断的替代方案（例如临床观察或透过病毒分离进行实验室确认）可能会与诊断测试竞争。

物流挑战：将检体从偏远地区运送到诊断实验室、管理低温运输以及按时完成测试和报告都具有物流挑战性，尤其是在服务不足和农村地区。

抵制变革：由于程序过时或缺乏现代技术经验，医疗保健系统和从业人员可能不愿意采用新的诊断工具和程序。

经济因素：预算限制和经济衰退可能会减少医疗支出，影响诊断检测的采用和整体市场扩张。狂犬病的感染疾病性意味着它可以传播给人类和动物。由于环境条件、人类健康和动物健康之间的通用相互作用，狂犬病的诊断和治疗可能带来特殊的挑战，需要多学科方法。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 狂犬病诊断市场（依诊断方法）

• 萤光抗体检测（FAT）
• 免疫组织化学（IHC）
• 扩增方法
• 组织学检查
• 血清学检测

5. 狂犬病诊断市场（依技术）

• ELISA/免疫组织化学（ELISA/IHC）
• 层析法技术
• PCR（聚合酵素链锁反应）

第六章 区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第七章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第八章 竞争态势

• 主要企业
• 市占率分析

第九章：公司简介

• Bio-Rad Laboratories, Inc.
• Aviva Systems Biology Corporation
• Norgen Biotek Corp.
• Demeditec Diagnostics GmbH
• Creative Diagnostics
• Abbexa Ltd.
• MyBioSource.com
• Express Biotech International Inc.
• BioNote, Inc.

第十章：市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十一章 市场展望 附录

• 简称列表
• 来源和参考文献

Rabies Diagnostics Market Size And Forecast

Rabies Diagnostics Market size was valued at USD 1.9 Billion in 2024 and is projected to reach USD 3.8 Billion by 2031, growing at a CAGR of 4.9% from 2024 to 2031.

Global Rabies Diagnostics Market Drivers

The market drivers for the Rabies Diagnostics Market can be influenced by various factors. These may include:

Rising Rabies Incidence: In order to identify diseased animals and stop human transmission, rabies diagnostics are becoming more and more necessary, especially in areas where vaccination programmes are less common.

Government Regulations And Initiatives: Mandatory rabies vaccination programmes for wildlife and pets are examples of government-led rabies control measures that may increase demand for rabies diagnostics. Market conditions may also be impacted by laws governing the import and export of animals.

Technological Advancements: The accuracy, speed, and convenience of diagnosing rabies are improved by advances in diagnostic technologies, including as molecular diagnostics (PCR), next-generation sequencing, and quick immunodiagnostic testing. This expands the market.

Growing Pet Ownership: As the number of people owning pets rises around the world, there is a greater need for rabies diagnostics for dogs, cats, and other household animals.

Public awareness campaigns and education initiatives regarding the dangers of rabies transmission and the value of early diagnosis can be the main drivers of the need for rabies diagnostics.

Worldwide Travel And Tourism: As a result of the increased danger of rabies transmission across countries, areas with significant tourist influxes must have a strong diagnostic infrastructure.

Animal Welfare Concerns: As awareness of animal welfare and the morality of treating animals grows, so does the need for precise and compassionate rabies testing techniques, which encourages the use of cutting-edge diagnostic technologies.

Outbreak Preparedness: To swiftly detect and contain outbreaks, especially in areas vulnerable to epidemics, governments and healthcare institutions invest in rabies diagnostics as part of their preparedness plans.

Research And Development: By generating new opportunities and spurring innovation, ongoing research and development efforts targeted at providing innovative diagnostic methods, vaccinations, and therapies for rabies help to expand the diagnostics industry.

Partnerships And Collaborations: By pooling resources and expertise, partnerships and collaborations between government agencies, research centres, and diagnostic companies help to create and commercialise new diagnostic instruments and propel market expansion.

Global Rabies Diagnostics Market Restraints

Several factors can act as restraints or challenges for the Rabies Diagnostics Market. These may include:

Regulatory Obstacles: Tight rules and lengthy approval procedures for diagnostic testing may impede the expansion of the market. For businesses launching new diagnostics, regulatory compliance may pose a serious obstacle.

Limited Infrastructure And Awareness: In areas where rabies is endemic, there may be insufficient healthcare infrastructure to provide widespread testing or a lack of knowledge of the significance of diagnostics.

High Costs: The price of diagnostic testing can be unaffordable, particularly in environments with limited resources. This may make diagnostics more difficult to get, especially in places where prevalence rates are high.

Technological Restrictions: The sensitivity, specificity, or speed of detection of current diagnostic techniques may be limited. To overcome these constraints, technological innovations in diagnostics are required.

Geographic Distribution Of Rabies: Because rabies is more common in some areas of the world, there may be less market opportunity for diagnostics in places with lower incidence rates.

Competition From Alternative Methods: In resource-constrained environments where economical solutions are favoured, alternative methods for diagnosing rabies, such as clinical observation or laboratory confirmation through virus isolation, may compete with diagnostic testing.

Logistical Difficulties: Sample transportation from remote locations to diagnostic labs, cold chain management, and making sure testing and reporting are completed on time can all be logistically difficult, particularly in underserved or rural areas.

Opposition To Change: Because of long-standing procedures or a lack of experience with more recent techniques, healthcare systems and practitioners may be reluctant to embrace new diagnostic tools or procedures.

Economic Factors: Financial strains or downturns may result in lower expenditure on healthcare, which may have an impact on the uptake of diagnostic tests and the expansion of the market as a whole. The zoonotic nature of rabies refers to the fact that the disease can infect both humans and animals. The intricate relationship among environmental conditions, human health, and animal health might create special difficulties for diagnosing and treating rabies, necessitating a multidisciplinary approach.

Global Rabies Diagnostics Market Segmentation Analysis

The Global Rabies Diagnostics Market is Segmented on the basis of Diagnostic Method, Technology, And Geography.

Rabies Diagnostics Market, By Diagnostic Method

Fluorescent Antibody Test (FAT): This is the gold standard for rabies diagnosis, but it requires specialized equipment and trained personnel.

Immunohistochemical Test (IHC): Similar to FAT, IHC is a confirmatory test that can identify rabies virus antigens in tissue samples.

Amplification Methods: These tests, like Polymerase Chain Reaction (PCR), can detect the rabies virus's genetic material, offering high sensitivity and specificity.

Histologic Examination: This method involves examining brain tissue samples under a microscope for signs of rabies infection.

Serology Tests: These tests measure antibodies against the rabies virus in a person's blood, indicating past exposure or vaccination.

Rabies Diagnostics Market, By Technology

ELISA/Immunohistochemistry (ELISA/IHC): These are common techniques used in various diagnostic tests, including rabies. ELISA involves an antigen-antibody reaction, while IHC uses antibodies to locate specific antigens in tissue samples.

Chromatography Techniques: These techniques separate components of a mixture, which can be helpful in rabies diagnosis for isolating the virus.

PCR (Polymerase Chain Reaction): A powerful technique for amplifying specific DNA sequences, allowing for highly sensitive detection of the rabies virus.

Rabies Diagnostics Market, By Geography

North America: Market conditions and demand in the United States, Canada, and Mexico.

Europe: Analysis of the Rabies Diagnostics Market in European countries.

Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.

Middle East and Africa: Examining market dynamics in the Middle East and African regions.

Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Rabies Diagnostics Market are:
• Bio-Rad Laboratories, Inc.
• Aviva Systems Biology Corporation
• Norgen Biotek Corp.
• Demeditec Diagnostics GmbH
• Creative Diagnostics
• Abbexa Ltd.
• MyBioSource.com
• Express Biotech International Inc.
• BioNote, Inc.
• Merck KGaA

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Rabies Diagnostics Market, By Diagnostic Method

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test (IHC)
• Amplification Methods
• Histologic Examination
• Serology Tests

5. Rabies Diagnostics Market, By Technology

• ELISA/Immunohistochemistry (ELISA/IHC)
• Chromatography Techniques
• PCR (Polymerase Chain Reaction)

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Bio-Rad Laboratories, Inc.
• Aviva Systems Biology Corporation
• Norgen Biotek Corp.
• Demeditec Diagnostics GmbH
• Creative Diagnostics
• Abbexa Ltd.
• MyBioSource.com
• Express Biotech International Inc.
• BioNote, Inc.

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References